Deubiquitinating Enzyme Inhibitors and their Potential in Cancer Therapy

E-ISSN： 1873-5576|14|6|506-516

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.14, Iss.6, 2014-07, pp. : 506-516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential of proteasome inhibitors in cancer therapy

By Sterz Jan Metzler Ivana von Hahne Jens-Claus Lamottke Britta Rademacher Jessica Heider Ulrike Terpos Evangelos Sezer Orhan

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 6, 2008-06 ,pp. : 879-895

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy

Current Cancer Drug Targets, Vol. 4, Iss. 7, 2004-11 ,pp. : 555-567

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Potential of Matrix Metalloprotease Inhibitors in Cancer Therapy

By Heath E.I.

Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. : 1043-1055

Adis International

Access to resources Recommend Favorite

Future potential of thymidylate synthase inhibitors in cancer therapy

By Lehman Norman L

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 12, 2002-12 ,pp. : 1775-1787

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of the Enzyme Purine Nucleoside Phosphorylase as Potential Therapy for Psoriasis

Current Pharmaceutical Design, Vol. 6, Iss. 9, 2000-06 ,pp. : 943-959

Bentham Science Publishers

Access to resources Recommend Favorite